
### [MONDO:0019187](http://purl.obolibrary.org/obo/MONDO_0019187)
**Label:** Axenfeld-Rieger syndrome

**Subclasses:** [MONDO:0011097](http://purl.obolibrary.org/obo/MONDO_0011097) (Axenfeld-Rieger syndrome type 2), [MONDO:0011233](http://purl.obolibrary.org/obo/MONDO_0011233) (Axenfeld-Rieger syndrome type 3), [MONDO:0008386](http://purl.obolibrary.org/obo/MONDO_0008386) (Axenfeld-Rieger syndrome type 1), 

**Mapped go classes:** [GO:0016525](http://purl.obolibrary.org/obo/GO_0016525) (negative regulation of angiogenesis), [GO:0003171](http://purl.obolibrary.org/obo/GO_0003171) (atrioventricular valve development), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0000977](http://purl.obolibrary.org/obo/GO_0000977) (RNA polymerase II regulatory region sequence-specific DNA binding), [GO:0090055](http://purl.obolibrary.org/obo/GO_0090055) (positive regulation of chromatin silencing at silent mating-type cassette), [GO:0000976](http://purl.obolibrary.org/obo/GO_0000976) (transcription regulatory region sequence-specific DNA binding), [GO:1902038](http://purl.obolibrary.org/obo/GO_1902038) (positive regulation of hematopoietic stem cell differentiation), [GO:0007535](http://purl.obolibrary.org/obo/GO_0007535) (donor selection), [GO:0003688](http://purl.obolibrary.org/obo/GO_0003688) (DNA replication origin binding), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0001822](http://purl.obolibrary.org/obo/GO_0001822) (kidney development), [GO:0048762](http://purl.obolibrary.org/obo/GO_0048762) (mesenchymal cell differentiation), [GO:0001944](http://purl.obolibrary.org/obo/GO_0001944) (vasculature development), [GO:0001945](http://purl.obolibrary.org/obo/GO_0001945) (lymph vessel development), [GO:0071930](http://purl.obolibrary.org/obo/GO_0071930) (negative regulation of transcription involved in G1/S transition of mitotic cell cycle), [GO:0021549](http://purl.obolibrary.org/obo/GO_0021549) (cerebellum development), [GO:0031076](http://purl.obolibrary.org/obo/GO_0031076) (embryonic camera-type eye development), [GO:0045930](http://purl.obolibrary.org/obo/GO_0045930) (negative regulation of mitotic cell cycle), [GO:0043114](http://purl.obolibrary.org/obo/GO_0043114) (regulation of vascular permeability), [GO:0046620](http://purl.obolibrary.org/obo/GO_0046620) (regulation of organ growth), [GO:0007420](http://purl.obolibrary.org/obo/GO_0007420) (brain development), [GO:0008354](http://purl.obolibrary.org/obo/GO_0008354) (germ cell migration), [GO:0061325](http://purl.obolibrary.org/obo/GO_0061325) (cell proliferation involved in outflow tract morphogenesis), [GO:0000981](http://purl.obolibrary.org/obo/GO_0000981) (RNA polymerase II transcription factor activity, sequence-specific DNA binding), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0048010](http://purl.obolibrary.org/obo/GO_0048010) (vascular endothelial growth factor receptor signaling pathway), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0071364](http://purl.obolibrary.org/obo/GO_0071364) (cellular response to epidermal growth factor stimulus), [GO:0001958](http://purl.obolibrary.org/obo/GO_0001958) (endochondral ossification), [GO:0071406](http://purl.obolibrary.org/obo/GO_0071406) (cellular response to methylmercury), [GO:0019237](http://purl.obolibrary.org/obo/GO_0019237) (centromeric DNA binding), [GO:0008283](http://purl.obolibrary.org/obo/GO_0008283) (cell proliferation), [GO:0008045](http://purl.obolibrary.org/obo/GO_0008045) (motor neuron axon guidance), [GO:0021538](http://purl.obolibrary.org/obo/GO_0021538) (epithalamus development), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0048536](http://purl.obolibrary.org/obo/GO_0048536) (spleen development), [GO:0009653](http://purl.obolibrary.org/obo/GO_0009653) (anatomical structure morphogenesis), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0001764](http://purl.obolibrary.org/obo/GO_0001764) (neuron migration), [GO:0048384](http://purl.obolibrary.org/obo/GO_0048384) (retinoic acid receptor signaling pathway), [GO:0051300](http://purl.obolibrary.org/obo/GO_0051300) (spindle pole body organization), [GO:0043010](http://purl.obolibrary.org/obo/GO_0043010) (camera-type eye development), [GO:0003705](http://purl.obolibrary.org/obo/GO_0003705) (transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding), [GO:0048387](http://purl.obolibrary.org/obo/GO_0048387) (negative regulation of retinoic acid receptor signaling pathway), [GO:0048382](http://purl.obolibrary.org/obo/GO_0048382) (mesendoderm development), [GO:0016477](http://purl.obolibrary.org/obo/GO_0016477) (cell migration), [GO:0035138](http://purl.obolibrary.org/obo/GO_0035138) (pectoral fin morphogenesis), [GO:0070986](http://purl.obolibrary.org/obo/GO_0070986) (left/right axis specification), [GO:1901491](http://purl.obolibrary.org/obo/GO_1901491) (negative regulation of lymphangiogenesis), [GO:0038084](http://purl.obolibrary.org/obo/GO_0038084) (vascular endothelial growth factor signaling pathway), [GO:0007520](http://purl.obolibrary.org/obo/GO_0007520) (myoblast fusion), [GO:0002074](http://purl.obolibrary.org/obo/GO_0002074) (extraocular skeletal muscle development), [GO:0048701](http://purl.obolibrary.org/obo/GO_0048701) (embryonic cranial skeleton morphogenesis), [GO:1901534](http://purl.obolibrary.org/obo/GO_1901534) (positive regulation of hematopoietic progenitor cell differentiation), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0090282](http://purl.obolibrary.org/obo/GO_0090282) (positive regulation of transcription involved in G2/M transition of mitotic cell cycle), [GO:0060412](http://purl.obolibrary.org/obo/GO_0060412) (ventricular septum morphogenesis), [GO:0007005](http://purl.obolibrary.org/obo/GO_0007005) (mitochondrion organization), [GO:0007368](http://purl.obolibrary.org/obo/GO_0007368) (determination of left/right symmetry), [GO:0001541](http://purl.obolibrary.org/obo/GO_0001541) (ovarian follicle development), [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis), [GO:0021763](http://purl.obolibrary.org/obo/GO_0021763) (subthalamic nucleus development), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0001654](http://purl.obolibrary.org/obo/GO_0001654) (eye development), [GO:0003713](http://purl.obolibrary.org/obo/GO_0003713) (transcription coactivator activity), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0001657](http://purl.obolibrary.org/obo/GO_0001657) (ureteric bud development), [GO:0007519](http://purl.obolibrary.org/obo/GO_0007519) (skeletal muscle tissue development), [GO:0061072](http://purl.obolibrary.org/obo/GO_0061072) (iris morphogenesis), [GO:0030199](http://purl.obolibrary.org/obo/GO_0030199) (collagen fibril organization), [GO:0035886](http://purl.obolibrary.org/obo/GO_0035886) (vascular smooth muscle cell differentiation), [GO:0040036](http://purl.obolibrary.org/obo/GO_0040036) (regulation of fibroblast growth factor receptor signaling pathway), [GO:0055010](http://purl.obolibrary.org/obo/GO_0055010) (ventricular cardiac muscle tissue morphogenesis), [GO:0008301](http://purl.obolibrary.org/obo/GO_0008301) (DNA binding, bending), [GO:0006366](http://purl.obolibrary.org/obo/GO_0006366) (transcription by RNA polymerase II), [GO:0048557](http://purl.obolibrary.org/obo/GO_0048557) (embryonic digestive tract morphogenesis), [GO:0043388](http://purl.obolibrary.org/obo/GO_0043388) (positive regulation of DNA binding), [GO:0003253](http://purl.obolibrary.org/obo/GO_0003253) (cardiac neural crest cell migration involved in outflow tract morphogenesis), [GO:0006369](http://purl.obolibrary.org/obo/GO_0006369) (termination of RNA polymerase II transcription), [GO:0001105](http://purl.obolibrary.org/obo/GO_0001105) (RNA polymerase II transcription coactivator activity), [GO:0060325](http://purl.obolibrary.org/obo/GO_0060325) (face morphogenesis), [GO:0001223](http://purl.obolibrary.org/obo/GO_0001223) (transcription coactivator binding), [GO:0001102](http://purl.obolibrary.org/obo/GO_0001102) (RNA polymerase II activating transcription factor binding), [GO:0001078](http://purl.obolibrary.org/obo/GO_0001078) (transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0003007](http://purl.obolibrary.org/obo/GO_0003007) (heart morphogenesis), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0001501](http://purl.obolibrary.org/obo/GO_0001501) (skeletal system development), [GO:1990841](http://purl.obolibrary.org/obo/GO_1990841) (promoter-specific chromatin binding), [GO:0032808](http://purl.obolibrary.org/obo/GO_0032808) (lacrimal gland development), [GO:0001503](http://purl.obolibrary.org/obo/GO_0001503) (ossification), [GO:0055123](http://purl.obolibrary.org/obo/GO_0055123) (digestive system development), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0001191](http://purl.obolibrary.org/obo/GO_0001191) (transcriptional repressor activity, RNA polymerase II transcription factor binding), [GO:0016055](http://purl.obolibrary.org/obo/GO_0016055) (Wnt signaling pathway), [GO:0072149](http://purl.obolibrary.org/obo/GO_0072149) (glomerular visceral epithelial cell fate commitment), [GO:0033339](http://purl.obolibrary.org/obo/GO_0033339) (pectoral fin development), [GO:0090419](http://purl.obolibrary.org/obo/GO_0090419) (negative regulation of transcription involved in G2/M transition of mitotic cell cycle), [GO:0055007](http://purl.obolibrary.org/obo/GO_0055007) (cardiac muscle cell differentiation), [GO:0035116](http://purl.obolibrary.org/obo/GO_0035116) (embryonic hindlimb morphogenesis), [GO:0055009](http://purl.obolibrary.org/obo/GO_0055009) (atrial cardiac muscle tissue morphogenesis), [GO:0045618](http://purl.obolibrary.org/obo/GO_0045618) (positive regulation of keratinocyte differentiation), [GO:0035993](http://purl.obolibrary.org/obo/GO_0035993) (deltoid tuberosity development), [GO:1902366](http://purl.obolibrary.org/obo/GO_1902366) (regulation of Notch signaling pathway involved in somitogenesis), [GO:0014032](http://purl.obolibrary.org/obo/GO_0014032) (neural crest cell development), [GO:0014031](http://purl.obolibrary.org/obo/GO_0014031) (mesenchymal cell development), [GO:0048844](http://purl.obolibrary.org/obo/GO_0048844) (artery morphogenesis), [GO:0021501](http://purl.obolibrary.org/obo/GO_0021501) (prechordal plate formation), [GO:0021986](http://purl.obolibrary.org/obo/GO_0021986) (habenula development), [GO:0060038](http://purl.obolibrary.org/obo/GO_0060038) (cardiac muscle cell proliferation), [GO:0005720](http://purl.obolibrary.org/obo/GO_0005720) (nuclear heterochromatin), [GO:0021983](http://purl.obolibrary.org/obo/GO_0021983) (pituitary gland development), [GO:0009887](http://purl.obolibrary.org/obo/GO_0009887) (animal organ morphogenesis), [GO:0072010](http://purl.obolibrary.org/obo/GO_0072010) (glomerular epithelium development), [GO:0007219](http://purl.obolibrary.org/obo/GO_0007219) (Notch signaling pathway), [GO:0000790](http://purl.obolibrary.org/obo/GO_0000790) (nuclear chromatin), [GO:0001755](http://purl.obolibrary.org/obo/GO_0001755) (neural crest cell migration), [GO:0072015](http://purl.obolibrary.org/obo/GO_0072015) (glomerular visceral epithelial cell development), [GO:0001756](http://purl.obolibrary.org/obo/GO_0001756) (somitogenesis), [GO:0050880](http://purl.obolibrary.org/obo/GO_0050880) (regulation of blood vessel size), [GO:0001085](http://purl.obolibrary.org/obo/GO_0001085) (RNA polymerase II transcription factor binding), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0036438](http://purl.obolibrary.org/obo/GO_0036438) (maintenance of lens transparency), [GO:2000288](http://purl.obolibrary.org/obo/GO_2000288) (positive regulation of myoblast proliferation), [GO:0055015](http://purl.obolibrary.org/obo/GO_0055015) (ventricular cardiac muscle cell development), [GO:0051219](http://purl.obolibrary.org/obo/GO_0051219) (phosphoprotein binding), [GO:0030334](http://purl.obolibrary.org/obo/GO_0030334) (regulation of cell migration), [GO:0051216](http://purl.obolibrary.org/obo/GO_0051216) (cartilage development), [GO:0035462](http://purl.obolibrary.org/obo/GO_0035462) (determination of left/right asymmetry in diencephalon), [GO:0061031](http://purl.obolibrary.org/obo/GO_0061031) (endodermal digestive tract morphogenesis), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0060460](http://purl.obolibrary.org/obo/GO_0060460) (left lung morphogenesis), [GO:0003350](http://purl.obolibrary.org/obo/GO_0003350) (pulmonary myocardium development), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0039021](http://purl.obolibrary.org/obo/GO_0039021) (pronephric glomerulus development), [GO:0042475](http://purl.obolibrary.org/obo/GO_0042475) (odontogenesis of dentin-containing tooth), [GO:1902257](http://purl.obolibrary.org/obo/GO_1902257) (negative regulation of apoptotic process involved in outflow tract morphogenesis), [GO:1903468](http://purl.obolibrary.org/obo/GO_1903468) (positive regulation of DNA replication initiation), [GO:1904798](http://purl.obolibrary.org/obo/GO_1904798) (positive regulation of core promoter binding), [GO:0021855](http://purl.obolibrary.org/obo/GO_0021855) (hypothalamus cell migration), [GO:0042476](http://purl.obolibrary.org/obo/GO_0042476) (odontogenesis), [GO:0001570](http://purl.obolibrary.org/obo/GO_0001570) (vasculogenesis), [GO:0048738](http://purl.obolibrary.org/obo/GO_0048738) (cardiac muscle tissue development), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0010718](http://purl.obolibrary.org/obo/GO_0010718) (positive regulation of epithelial to mesenchymal transition), [GO:0048341](http://purl.obolibrary.org/obo/GO_0048341) (paraxial mesoderm formation), [GO:0006338](http://purl.obolibrary.org/obo/GO_0006338) (chromatin remodeling), [GO:0001568](http://purl.obolibrary.org/obo/GO_0001568) (blood vessel development), [GO:0001569](http://purl.obolibrary.org/obo/GO_0001569) (branching involved in blood vessel morphogenesis), [GO:1990869](http://purl.obolibrary.org/obo/GO_1990869) (cellular response to chemokine), [GO:0030325](http://purl.obolibrary.org/obo/GO_0030325) (adrenal gland development), [GO:0030203](http://purl.obolibrary.org/obo/GO_0030203) (glycosaminoglycan metabolic process), [GO:0030324](http://purl.obolibrary.org/obo/GO_0030324) (lung development), [GO:0061386](http://purl.obolibrary.org/obo/GO_0061386) (closure of optic fissure), [GO:0031490](http://purl.obolibrary.org/obo/GO_0031490) (chromatin DNA binding), [GO:0061300](http://purl.obolibrary.org/obo/GO_0061300) (cerebellum vasculature development), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0060971](http://purl.obolibrary.org/obo/GO_0060971) (embryonic heart tube left/right pattern formation), [GO:0034244](http://purl.obolibrary.org/obo/GO_0034244) (negative regulation of transcription elongation from RNA polymerase II promoter), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0071907](http://purl.obolibrary.org/obo/GO_0071907) (determination of digestive tract left/right asymmetry), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0035050](http://purl.obolibrary.org/obo/GO_0035050) (embryonic heart tube development), [GO:0061303](http://purl.obolibrary.org/obo/GO_0061303) (cornea development in camera-type eye), [GO:0060577](http://purl.obolibrary.org/obo/GO_0060577) (pulmonary vein morphogenesis), [GO:0060578](http://purl.obolibrary.org/obo/GO_0060578) (superior vena cava morphogenesis), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0048593](http://purl.obolibrary.org/obo/GO_0048593) (camera-type eye morphogenesis), [GO:0001974](http://purl.obolibrary.org/obo/GO_0001974) (blood vessel remodeling), [GO:0070098](http://purl.obolibrary.org/obo/GO_0070098) (chemokine-mediated signaling pathway), [GO:0048596](http://purl.obolibrary.org/obo/GO_0048596) (embryonic camera-type eye morphogenesis), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0031124](http://purl.obolibrary.org/obo/GO_0031124) (mRNA 3'-end processing), [GO:0034599](http://purl.obolibrary.org/obo/GO_0034599) (cellular response to oxidative stress), [GO:0032298](http://purl.obolibrary.org/obo/GO_0032298) (positive regulation of DNA-dependent DNA replication initiation), [GO:2000221](http://purl.obolibrary.org/obo/GO_2000221) (negative regulation of pseudohyphal growth), [GO:2000583](http://purl.obolibrary.org/obo/GO_2000583) (regulation of platelet-derived growth factor receptor-alpha signaling pathway), 

**Class expressions from DL-Learner:**

- Thing 55.46%
- [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) 52.57%
- [GO:0061325](http://purl.obolibrary.org/obo/GO_0061325) (cell proliferation involved in outflow tract morphogenesis) 50.68%
- [GO:0061323](http://purl.obolibrary.org/obo/GO_0061323) (cell proliferation involved in heart morphogenesis) 50.68%
- [GO:0060038](http://purl.obolibrary.org/obo/GO_0060038) (cardiac muscle cell proliferation) 50.68%
- [GO:0001541](http://purl.obolibrary.org/obo/GO_0001541) (ovarian follicle development) 50.68%
- [GO:0032502](http://purl.obolibrary.org/obo/GO_0032502) (developmental process) 41.18%
- [GO:0033002](http://purl.obolibrary.org/obo/GO_0033002) (muscle cell proliferation) 36.04%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) 36.04%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 36.04%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 36.04%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 36.04%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 36.04%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 36.04%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:2001052](http://purl.obolibrary.org/obo/GO_2001052) (null)) 36.04%


